20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T10276L | AKT Kinase Inhibitor HCl | AKT Kinase Inhibitor HCl(842148-40-7 Free base) | Akt |
AKT Kinase Inhibitor HCl is an Akt inhibitor with antitumor activity. | |||
T3346 | AKT inhibitor VIII | AKTi-1/2 | Apoptosis , Akt |
AKT inhibitor VIII (AKTi-1/2) is a highly specific Akt1/2 inhibitor (IC50: 58/210 nM). The selectivity for Akt1 is higher about 36-fold than Akt3. | |||
T10276 | AKT Kinase Inhibitor | Akt | |
AKT Kinase Inhibitor is an Akt inhibitor with antitumor activity that selectively inhibits cell proliferation in a dose-dependent manner. | |||
T25017 | AKT-I-1 | Akt | |
AKT-I-1 is a selective and reversible inhibitor of Akt1. | |||
T23695 | Akt-I-1,2 | Akt | |
Akt-I-1,2 is a selective inhibitor of Akt1 and Akt2. | |||
T36310 | AKT-IN-6 | INCB-047775 | Akt |
AKT-IN-6 (INCB-047775) has an inhibitory effect on ATK. Akt is an important component of cellular signaling for growth factors, cytokines, and other cell stimuli. Abnormal Akt activation has been associated with the deve... | |||
T9393 | (E)-Akt inhibitor-IV | (E)-AKTIV,CS-1992 | Akt |
(E)-Akt inhibitor-IV ((E)-AKTIV) ((E)-AKTIV) is an inhibitor of PI3K-Akt. | |||
T4489 | AKT-IN-1 | AZD26,AZD-26,AZD 26 | Akt |
AKT-IN-1 (AZD-26) is an allosteric AKT inhibitor (IC50: 1.04 μM). | |||
T60564 | PI3K/Akt/mTOR-IN-2 | Apoptosis , Akt , PI3K , mTOR | |
PI3K/Akt/mTOR-IN-2 is a potent PI3K/AKT/mTOR inhibitor.PI3K/Akt/mTOR-IN-2 has anticancer effects and is selective for MDA-MB-231 cells with an IC50 of 2.29 μM.PI3K/Akt/mTOR-IN-2 exhibits anticancer activity and induces c... | |||
T5508 | PF-AKT400 | AKT protein kinase inhibitor | Akt |
PF-AKT400 (AKT protein kinase inhibitor) is a broadly selective and ATP-competitive inhibitor of Akt. | |||
T3467 | Miransertib | ARQ-092,AKT inhibitor 2 | Akt , Parasite |
Miransertib (ARQ-092) is an orally bioavailable, selective, and potent allosteric Akt inhibitor. | |||
T23694 | Akt Inhibitor X | aktX,CCG 206734,Akt Inhibitor-X,CCG-206734,10-DEBC hydrochloride | |
Akt Inhibitor X is a cell-permeable and reversible inhibitor of Akt phosphorylation. | |||
T10275 | AKT-IN-3 | Akt | |
AKT-IN-3 is a potent, orally active low hERG blocking Akt inhibitor (IC50: 1.4 nM, 1.2 nM, and 1.7 nM for Akt1, Akt2, and Akt3). AKT-IN-3 (compound E22) also exhibits good inhibitory activity against other AGC family kin... | |||
T10274 | AKT-IN-2 | Akt | |
AKT-IN-2 is a selective, and orally bioavailable AKT inhibitor (IC50: 5 nM for AKT1). | |||
TP2175 | Akt/SKG Substrate Peptide | Others | |
substrate for Akt/PKB | |||
T71272 | PI3K/Akt-IN-C89 | ||
PI3K/Akt-IN-C89 is a novel Inhibitor of the PI3K-Akt Pathway, Inducing Autophagy of Female Germline Stem Cells. | |||
T62771 | AKT-IN-9 | ||
AKT-IN-9 is a potent inhibitor of AKT. AKT-IN-9 has potential for breast and prostate cancer research. | |||
T63211 | AKT-IN-10 | ||
AKT-IN-10 is a potent AKT inhibitor that has shown research potential in breast and prostate cancers. Among them is protein kinase B (PKB, also known as AKT), which is central to PI3K/AKT/mTOR signaling in cells and whos... | |||
T62807 | AKT-IN-7 | ||
AKT-IN-7 (compound 1-P1) is a potent inhibitor of AKT. AKT-IN-7 has potential for cancer research. | |||
T63039 | AKT-IN-13 | ||
AKT-IN-13 (compound 4b) is a potent inhibitor of Akt, acting on Akt1 (IC50: 1.6 nM), Akt2 (IC50: 2.4 nM) and Akt3 (IC50: 0.3 nM). AKT-IN-13 can be used in anticancer research. |